[Stent therapy with diabetic patients who have coronary artery disease].
When bare-metal stents are used, diabetic patients with coronary artery disease have a poorer prognosis than non-diabetic patients after coronary interventions. In clinical studies, it could be demonstrated that the disadvantage for diabetic patients is not present when drug-eluting stents are used. Today, two types of drug-eluting stents are clinically used: the sirolimus-eluting stent (Cypher) and the paclitaxel-eluting stent (Taxus). Even the high risk group of patients with in-stent stenosis can be efficiently treated with drug-eluting stents.
Motz
W
W
Klinikum Karlsburg, Herz- u. Diabeteszentrum Mecklenburg-Vorpommern, Greifswalder Strasse 11, 17495 Karlsburg, Germany.
Kaiser
R
R
D003324:Coronary Artery Disease / Q000209:etiology / Q000628:therapy*; D048909:Diabetes Complications; D003920:Diabetes Mellitus; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage; D011379:Prognosis; D012307:Risk Factors; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents
D017239:Paclitaxel; D020123:Sirolimus